Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients
Standard
Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients. / Velavan, Thirumalaisamy P; Kuk, Salih; Linh, Le Thi Kieu; Lamsfus Calle, Carlos; Lalremruata, Albert; Pallerla, Srinivas Reddy; Kreidenweiss, Andrea; Held, Jana; Esen, Meral; Gabor, Julian; Neurohr, Eva Maria; Shamsrizi, Parichehr; Fathi, Anahita; Biecker, Erwin; Berg, Christoph P; Ramharter, Michael; Addo, Marylyn Martina; Kreuels, Benno; Kremsner, Peter G.
In: SCI REP-UK, Vol. 11, No. 1, 14471, 14.07.2021.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients
AU - Velavan, Thirumalaisamy P
AU - Kuk, Salih
AU - Linh, Le Thi Kieu
AU - Lamsfus Calle, Carlos
AU - Lalremruata, Albert
AU - Pallerla, Srinivas Reddy
AU - Kreidenweiss, Andrea
AU - Held, Jana
AU - Esen, Meral
AU - Gabor, Julian
AU - Neurohr, Eva Maria
AU - Shamsrizi, Parichehr
AU - Fathi, Anahita
AU - Biecker, Erwin
AU - Berg, Christoph P
AU - Ramharter, Michael
AU - Addo, Marylyn Martina
AU - Kreuels, Benno
AU - Kremsner, Peter G
N1 - © 2021. The Author(s).
PY - 2021/7/14
Y1 - 2021/7/14
N2 - Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all ambulatory patients were SARS-CoV-2 positive at recruitment. Hospitalized patients had higher D-dimer, CRP and ferritin, cardiac troponin I and IL-6 levels than ambulatory patients (p < 0.001, p < 0.001, p = 0.016, p = 0.035, p = 0.002 respectively). Hospitalized patients experienced significant decreases in CRP, ferritin and IL-6 levels from admission to recovery (p < 0.001, p = 0.025, and p = 0.001 respectively). Cardiac troponin I levels were high during the acute phase in both hospitalized and ambulatory patients, indicating a potential myocardial injury. In summary, D-dimer, CRP, ferritin, cardiac troponin I, IL-6 are predictive laboratory markers and can largely determine the clinical course of COVID-19, in particular the prognosis of critically ill COVID-19 patients.
AB - Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all ambulatory patients were SARS-CoV-2 positive at recruitment. Hospitalized patients had higher D-dimer, CRP and ferritin, cardiac troponin I and IL-6 levels than ambulatory patients (p < 0.001, p < 0.001, p = 0.016, p = 0.035, p = 0.002 respectively). Hospitalized patients experienced significant decreases in CRP, ferritin and IL-6 levels from admission to recovery (p < 0.001, p = 0.025, and p = 0.001 respectively). Cardiac troponin I levels were high during the acute phase in both hospitalized and ambulatory patients, indicating a potential myocardial injury. In summary, D-dimer, CRP, ferritin, cardiac troponin I, IL-6 are predictive laboratory markers and can largely determine the clinical course of COVID-19, in particular the prognosis of critically ill COVID-19 patients.
KW - Ambulatory Care
KW - Biomarkers/blood
KW - C-Reactive Protein/analysis
KW - COVID-19/blood
KW - Early Diagnosis
KW - Ferritins/blood
KW - Fibrin Fibrinogen Degradation Products/analysis
KW - Follow-Up Studies
KW - Hospitalization
KW - Humans
KW - Interleukin-6/blood
KW - Longitudinal Studies
KW - Pneumonia, Viral/blood
KW - Precision Medicine
KW - Prognosis
KW - Quarantine
KW - SARS-CoV-2
KW - Severity of Illness Index
KW - Troponin I/blood
U2 - 10.1038/s41598-021-93950-x
DO - 10.1038/s41598-021-93950-x
M3 - SCORING: Journal article
C2 - 34262116
VL - 11
JO - SCI REP-UK
JF - SCI REP-UK
SN - 2045-2322
IS - 1
M1 - 14471
ER -